StockComparison Logo
vs

AKUS vs ALLO

Comparison between Akouos Inc (AKUS, Company) and Allogene Therapeutics Inc (ALLO, Company).

AKUS vs ALLO - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
AKUS
$490M
ALLO
$490M
Max Drawdown
Winner
AKUS
90.86%
ALLO
98.24%
Sharpe Ratio
AKUS
0.86
Winner
ALLO
0.89
5Y Beta
AKUS
N/A
ALLO
1.55
Industry
AKUS
N/A
ALLO
Biotechnology
P/E Ratio
Winner
AKUS
-5.30
ALLO
-2.63
5Y EPS CAGR
AKUS
N/A
ALLO
-14.18%
Debt to Equity
AKUS
0.00%
ALLO
0.00%
Free Cash Flow Yield
Winner
AKUS
-15.58%
ALLO
-22.37%
P/B Ratio
AKUS
2.71
ALLO
N/A

AKUS vs ALLO - Historical Returns

Returns include dividend reinvestment.

1M
AKUS
+0.00%
Winner
ALLO
+3.09%
3M
Winner
AKUS
+95.44%
ALLO
-6.98%
6M
Winner
AKUS
+327.33%
ALLO
+40.85%
1Y
AKUS
+46.37%
Winner
ALLO
+55.04%
5Y(CAGR)
AKUS
N/A
ALLO
-39.41%
Max(CAGR)
Winner
AKUS
-18.12%
ALLO
-28.01%

AKUS vs ALLO - Annual Returns (2018 - 2026)

Returns include dividend reinvestment.

YearAKUSALLO
2026N/A+48.15%
2025N/A-37.73%
2024N/A-41.16%
2023+0.00%-44.27%
2022+46.37%-58.86%
2021-56.25%-42.15%
2020-9.86%-3.74%
2019N/A-5.73%
2018N/A+7.72%

AKUS vs ALLO Drawdown Comparison

The maximum drawdown for AKUS was -90.86%, occurring on May 25, 2022. This drawdown has not yet recovered.

The maximum drawdown for ALLO was -98.24%, occurring on May 14, 2025. This drawdown has not yet recovered.

The current AKUS drawdown is -50.63%. The current ALLO drawdown is -96.30%.

RankAKUSALLO
#1-90.86%
Sep 14, 2020 - May 25, 2022
-98.24%
May 22, 2020 - May 14, 2025
#2-14.22%
Jun 30, 2020 - Aug 28, 2020
-45.29%
Nov 6, 2018 - May 11, 2020
#3-7.97%
Sep 2, 2020 - Sep 8, 2020
-16.54%
Oct 15, 2018 - Nov 2, 2018
#4-4.37%
Sep 9, 2020 - Sep 14, 2020
-7.25%
May 11, 2020 - May 14, 2020
#5-0.80%
Aug 28, 2020 - Sep 1, 2020
-0.39%
May 18, 2020 - May 20, 2020

Correlation

Correlation between AKUS and ALLO is 0.81 which considered as a strong positive correlation - the stocks tend to move together.

0.81
-101

Select Stocks to Compare